Your browser doesn't support javascript.
loading
Concurrent definitive chemoradiation incorporating intensity-modulated radiotherapy followed by adjuvant chemotherapy in high risk locally advanced cervical squamous cancer: a phase II study.
Zhang, Gong-Yi; Zhang, Rong; Bai, Ping; Li, Shu-Min; Zhang, Yuan-Yuan; Chen, Yi-Ran; Huang, Man-Ni; Wu, Ling-Ying.
Affiliation
  • Zhang GY; Department of Gynecological Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, NO.17 Panjiayuan, Chaoyang District, Beijing, 100021, China.
  • Zhang R; Department of Gynecological Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, NO.17 Panjiayuan, Chaoyang District, Beijing, 100021, China.
  • Bai P; Department of Gynecological Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, NO.17 Panjiayuan, Chaoyang District, Beijing, 100021, China.
  • Li SM; Department of Gynecological Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, NO.17 Panjiayuan, Chaoyang District, Beijing, 100021, China.
  • Zhang YY; Department of Gynecological Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, NO.17 Panjiayuan, Chaoyang District, Beijing, 100021, China.
  • Chen YR; Department of Gynecological Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, NO.17 Panjiayuan, Chaoyang District, Beijing, 100021, China.
  • Huang MN; Department of Gynecological Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, NO.17 Panjiayuan, Chaoyang District, Beijing, 100021, China. huangmanni@csco.org.cn.
  • Wu LY; Department of Gynecological Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, NO.17 Panjiayuan, Chaoyang District, Beijing, 100021, China. wulingying@csco.org.cn.
BMC Cancer ; 22(1): 1331, 2022 Dec 20.
Article in En | MEDLINE | ID: mdl-36539745
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Carcinoma, Squamous Cell / Uterine Cervical Neoplasms / Radiotherapy, Intensity-Modulated / Leukopenia Type of study: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Carcinoma, Squamous Cell / Uterine Cervical Neoplasms / Radiotherapy, Intensity-Modulated / Leukopenia Type of study: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Country of publication: